Underlying IPEX syndrome in a patient with idiopathic juvenile arthritis and vitiligo

Imagem de Miniatura
Arquivos
art_MENDONCA_Underlying_IPEX_syndrome_in_a_patient_with_idiopathic_2022.PDF (921.09 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
Citação
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, v.18, n.1, article ID 105, 6p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: IPEX syndrome is an X-linked inborn error of immunity clinically characterized by the triad of: enteropathy, polyendocrinopathy and eczema. However many other clinical presentations lacking the triad above described have been reported what underpin the need of careful clinical suspicion, immunological evaluation and genetic sequencing. Case presentation: Here we report a case of a Brazilian boy with severe eczema as the first and only presentation requiring cyclosporin therapy. Progressive and cumulative symptoms of arthritis and enteropathy lead to the suspicion of an inborn error of immunity. Peripheral FOXP3 expression was normal (CD127-/CD4+/CD25+/FOXP3+-396 cells-63%) and a pathogenic mutation in FOXP3 gene (c.1150G > A; p.Ala384Thr), confirmed the diagnosis of IPEX syndrome. Conclusions: IPEX syndrome should be suspected in patients presenting with severe eczema associated or not with other autoimmune/hyper inflammatory diseases in life. Our study also reinforces that FOXP3 expression by flowcytometry seems not to be a good screening method, and genetic sequencing is mandatory even in those with high suspicion and normal peripheral FOXP3 expression.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/51394
Referências
  1. Al Maawali A, 2020, CASE REP IMMUNOL, V2020, DOI 10.1155/2020/9860863
  2. Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011
  3. Bachelerie M, 2019, ANN DERMATOL VENER, V146, P807, DOI 10.1016/j.annder.2019.04.026
  4. Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041
  5. Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713
  6. CARNEIROSAMPAIO MMS, 1989, ALLERGOL IMMUNOPATH, V17, P213
  7. Castagnoli R, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2021.100513
  8. Gambineri E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02411
  9. Ge T, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00267
  10. Gentile M, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.854749
  11. Jahan P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00249
  12. Kanegane H, 2018, ALLERGOL INT, V67, P43, DOI 10.1016/j.alit.2017.06.003
  13. Park JH, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102526
  14. Toyama D, 2021, J CLIN IMMUNOL, V41, P1683, DOI 10.1007/s10875-021-01092-6
  15. Zama D, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0068-4

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/19
Artigos e Materiais de Revistas Científicas - LIM/36
Carregar mais